Pontifax backs UK gene editing company in $10 million A round

Tropic Biosciences is developing decaffeinated coffee varieties and bananas with a longer shelf life using CRISPR gene editing technology that Pontifax managing partner Ben Belldegrun tells Agri Investor is drawing biotech investors into the market.